All Journal Guides

Journal Guide

Circulation Research Impact Factor 16.5: Publishing Guide

The top journal for basic cardiovascular science, where mechanistic depth matters more than clinical translation. If your work reveals how hearts and vessels actually function at the molecular level, this is where it belongs.

16.5

Impact Factor (2024)

~10%

Acceptance Rate

21-35 days for initial decision

Time to First Decision

What Circulation Research Publishes

Circulation Research isn't looking for clinical trials or patient outcomes data - that's Circulation's territory. What editors want here is fundamental discovery: the molecular, cellular, and genetic mechanisms that explain why cardiovascular systems work or fail. Your paper needs to advance understanding of basic biology, even if it has obvious clinical implications down the road. The journal's sweet spot is work that changes how we think about cardiovascular physiology or pathophysiology. If you've discovered a new signaling pathway in cardiomyocytes, identified a genetic driver of vascular disease, or revealed how immune cells interact with heart tissue in ways nobody anticipated, you're in the right place. Papers that merely describe phenomena without explaining mechanisms don't make it past the editor's desk.

  • Molecular and cellular mechanisms of cardiac development, function, and remodeling - particularly ion channel biology, sarcomeric protein processes, and metabolic regulation in cardiomyocytes.
  • Vascular biology including endothelial cell signaling, smooth muscle cell phenotype switching, and the molecular basis of atherosclerosis, aneurysm formation, and microvascular disease.
  • Cardiac electrophysiology at the mechanistic level - ion channel genetics, action potential regulation, and the cellular basis of arrhythmias rather than clinical EP studies.
  • Inflammation and immunity in cardiovascular disease, especially macrophage biology, innate immune responses in heart failure, and neuroimmune interactions in hypertension.
  • Genetic and epigenetic mechanisms underlying congenital heart disease, cardiomyopathies, and inherited arrhythmia syndromes, with functional validation of variants.

Editor Insight

I see about 60 manuscripts a week, and I can tell within the first two paragraphs whether a paper belongs here. What kills submissions fastest isn't bad science - it's wrong scope. Clinical outcomes, epidemiology, health services research - those go to our sister journals. We want mechanism. I need to see that you've dissected why something happens at the molecular level, not just that it happens. The other thing that frustrates me is authors who don't read our recent issues. If we've published three papers on your exact pathway in the last six months, your novelty claim needs to be rock solid. We're not opposed to confirmatory work, but you need to bring something genuinely new. On the positive side, we do appreciate clean, well-controlled studies even when they're not flashy. A beautiful set of experiments that definitively answers a focused question beats a sprawling paper that tries to do everything but proves nothing conclusively. Don't pad your paper hoping more figures equals more impact.

What Circulation Research Editors Look For

Mechanistic depth over phenomenology

Editors at Circ Res have zero patience for papers that simply observe something happens without explaining why. If you're showing that treatment X improves cardiac function, you'd better have three figures demonstrating the molecular pathway responsible. The journal has explicitly stated it wants papers that 'provide fundamental insights into mechanisms' - they mean it. Accepted papers typically include genetic knockouts, rescue experiments, and biochemical dissection of pathways. A purely descriptive study, no matter how interesting the observation, won't survive peer review.

Novel findings that change understanding

Incremental advances don't cut it here. Your work needs to either identify something entirely new or substantially revise current understanding. That doesn't mean every paper has to overthrow textbooks, but there's a clear distinction between 'another paper about AMPK in the heart' and 'a paper that reveals AMPK does something nobody realized.' Reviewers are asked specifically whether findings are novel enough for Circ Res. If your main contribution is confirming what others have shown, even with better methods, you'll get redirected to a specialty journal.

Technical rigor with appropriate controls

The cardiovascular field has been burned by reproducibility failures, and Circ Res editors are vigilant. Expect detailed scrutiny of your sample sizes, blinding procedures, and statistical approaches. For animal studies, both male and female animals are required unless you provide biological justification otherwise. Cell line authentication isn't optional. If you're using genetic models, littermate controls are expected. Reviewers regularly request additional controls, and papers get rejected for inadequate rigor regardless of how exciting the biology seems.

Appropriate use of multiple model systems

Single-model papers face an uphill battle. The strongest submissions validate key findings across cell culture, animal models, and where possible, human tissue or genetics data. That doesn't mean you need all three for every claim, but your central discovery should hold up in more than one system. A finding that only appears in HEK cells or only in one mouse strain will be viewed skeptically. Editors explicitly look for translational relevance, which requires showing mechanisms operate in contexts beyond your primary model.

Clear connection to cardiovascular disease or physiology

Basic science journals sometimes publish elegant mechanism papers with tenuous disease connections. Circ Res isn't one of them. Your work needs a clear line to cardiovascular health or disease, articulated in your introduction and revisited in your discussion. That doesn't mean you need patient data, but you do need to explain why your findings matter for understanding cardiovascular biology. Purely developmental studies are fine if the mechanism has implications for congenital disease. Pure biochemistry is fine if the pathway operates in cardiac or vascular cells. What's not fine is a mechanism study that happens to use cardiomyocytes as a model but could have been done in any cell type.

Why Papers Get Rejected

These patterns appear repeatedly in manuscripts that don't make it past Circulation Research's editorial review:

Submitting clinical or epidemiological studies

This happens more than you'd think, especially with papers involving human cohorts. Circ Res doesn't publish patient outcomes studies, clinical trials, or epidemiological analyses - those belong in Circulation, Circulation: Cardiovascular Quality and Outcomes, or the specialty journals. Even if your clinical study includes some mechanistic biomarker work, if the primary question is about patient outcomes, it's going to the wrong journal. Desk rejection rates for mismatched scope are significant. Check recent tables of contents before assuming your paper fits.

Insufficient mechanistic explanation

The most common reviewer criticism is 'the mechanism isn't sufficiently addressed.' Authors frequently describe that something happens - cardiac remodeling, vascular dysfunction, altered electrophysiology - without drilling into why at the molecular level. If your paper shows knockout mice have a phenotype, reviewers will ask what the protein actually does, what its binding partners are, what downstream signaling changes. You'll be asked to add experiments, and sometimes those requests are essentially impossible to satisfy in revision. Better to include that depth from the start.

Over-reliance on a single experimental approach

Papers built entirely on pharmacological inhibitors, or entirely on one type of genetic manipulation, or entirely on cell culture raise red flags. Each approach has limitations, and reviewers know them. Inhibitor studies without genetic confirmation leave room for off-target effects. Knockout studies without rescue suggest you might have developmental compensation. In vitro findings without any in vivo validation seem disconnected from real physiology. The expectation isn't that every experiment must be replicated five ways, but that your core claims have orthogonal support.

Inadequate statistical reporting and power

Circ Res has tightened statistical requirements considerably. Underpowered animal studies get flagged immediately. The journal expects exact n values, not ranges. They want individual data points shown, not just bars with error bars. Sample size justifications for animal work are scrutinized. If you're using parametric tests, reviewers will ask if you verified normality. Papers have been rejected in revision for statistical problems that could have been avoided with proper planning. Read the statistical requirements document before starting your study, not after.

Ignoring sex as a biological variable

The journal enforces NIH policies requiring studies in both male and female animals unless there's specific biological justification. This isn't just about including both sexes - if you find sex differences, you need to report them. If you find no differences, you need statistical support for that conclusion, not just a statement that 'results were similar.' Studies conducted entirely in male animals with no justification will be returned. This catches many international researchers whose home countries don't have equivalent requirements. Check before you start the experiments.

Does your manuscript avoid these patterns?

The quick diagnostic reads your full manuscript against Circulation Research's criteria and flags the specific issues most likely to cause rejection.

Run Free Readiness Scan →

Insider Tips from Circulation Research Authors

The cover letter matters more than at most journals

Associate editors make triage decisions fast, and a good cover letter helps. Don't summarize the abstract - explain why this work is important for the field, what question it answers, and why it fits Circ Res specifically rather than Circulation or a subspecialty journal. If there's an obvious competitor journal that might have been a natural fit, explain why you chose Circ Res. Editors appreciate when authors demonstrate they understand the journal's scope.

Compendium Reviews are invitation-only, but you can suggest yourself

The journal's review articles carry significant weight in the field, and while they're technically by invitation, editors do consider unsolicited proposals. If you've got a unique perspective on an emerging area, a concise proposal to the editor can work. Don't just offer to review a broad topic - identify a specific angle, explain why now is the right time, and show you're positioned to write authoritatively. About one in four proposals get accepted for development.

Response to reviewers is where papers get saved or killed

A surprising number of provisionally promising papers fail because authors respond defensively to criticism. Circ Res editors pay attention to tone. If a reviewer asks for an experiment you can't do, explain the technical barriers and offer alternative evidence - don't argue that the experiment is unnecessary. Point-by-point responses should be thorough but not combative. When reviewers disagree with each other, don't play them off against one another. Editors notice.

Graphical abstracts significantly increase social media visibility

While optional, graphical abstracts dramatically affect how papers get promoted on the journal's social channels. Papers with compelling visual summaries get featured more prominently. The journal's Twitter/X account has substantial reach in cardiovascular research communities. If you want your work seen beyond the people who would find it through keyword searches, invest time in a clear, visually appealing graphical abstract.

Online-only supplemental data is treated seriously by reviewers

Some journals treat supplements as a dumping ground, but Circ Res reviewers examine supplementary figures carefully. Don't bury essential controls there hoping nobody will notice problems. At the same time, don't pad your supplement with marginally relevant experiments hoping it looks more substantial. The supplement should contain material that supports the main figures but isn't essential for the core narrative. Reviewers often comment on supplement quality.

The Circulation Research Submission Process

1

Pre-submission inquiry (optional but recommended for uncertain scope)

2-5 days for response

If you're unsure whether your paper fits Circ Res or should go to Circulation or a specialty journal, a brief email to the editorial office can save weeks. Include your abstract and a sentence about why you think this is basic rather than clinical science. You'll typically hear back within a few days. This isn't a guarantee of acceptance, but it prevents obvious mismatches.

2

Online submission through Editorial Manager

1-2 hours to complete

The submission portal requires standard elements: cover letter, title page with author contributions and conflicts, abstract, main text, figures, and supplementary materials. ORCID IDs are required for all authors. You'll need to complete an author checklist that includes questions about data availability, statistical methods, and inclusion criteria. Budget 90 minutes for a new submission.

3

Editorial triage

7-14 days

An associate editor reviews for scope fit and basic quality. About 40-50% of submissions are declined at this stage without external review, primarily for scope mismatch, insufficient novelty, or obvious methodological problems. If your paper passes triage, it goes to external reviewers. You won't receive detailed feedback on triaged papers, just a brief indication that it doesn't meet criteria.

4

Peer review

14-28 days

Typically two to three reviewers are assigned. Circ Res uses single-blind review - reviewers know your identity but you don't know theirs. Reviewers are asked about novelty, mechanistic depth, rigor, and fit for the journal. Review turnaround has improved, though during heavy submission periods it can extend beyond the target timeline. Reviewers increasingly request additional experiments.

5

Editorial decision

3-7 days after reviews complete

Decisions come as accept (rare on first round), minor revision, major revision, or reject. Major revisions typically mean substantive new experiments are expected - this isn't a formatting exercise. You'll have 60 days for major revisions, 30 for minor. The associate editor will indicate which reviewer concerns are essential versus optional to address. Read carefully - not everything asked for is required.

6

Post-acceptance production

2-4 weeks to publication

After acceptance, you'll receive proofs within about two weeks. Circ Res has a fast production timeline compared to some journals. Open access decisions are made at this stage if you didn't select it initially. The journal offers a Read for Free option that allows anyone to view but not download. Accepted manuscripts are posted rapidly while final versions are prepared.

Circulation Research by the Numbers

2024 Impact Factor(Consistently among the top basic cardiovascular science journals)16.5
Acceptance Rate(Desk rejection accounts for roughly half of all decisions)~10%
Time to First Decision(Varies by reviewer availability and revision requests)21-35 days
CiteScore (Scopus 2024)(Strong citation performance relative to cardiovascular science)24.3
Submissions per Year(High-volume journal with selective acceptance)~3,000
Open Access Rate(Optional gold open access with APC; many authors choose subscription model)~35%

Before you submit

Circulation Research accepts a small fraction of submissions. Make your attempt count.

The pre-submission diagnostic runs a live literature search, scores your manuscript section by section, and gives you a prioritized fix list calibrated to Circulation Research. ~30 minutes.

Article Types

Original Research Article

5,000 words excluding references and legends

Full-length reports of original basic science research. These form the core of the journal. Structured with introduction, methods, results, and discussion. Figures typically limited to 8, with additional material in supplement.

Brief Communication

2,500 words, 4 figures maximum

Shorter reports of focused findings that don't require full article treatment. Not lower quality - just more focused scope. These can work well for single-mechanism stories or confirmatory studies with novel angles.

Compendium Reviews

6,000-8,000 words by arrangement

Invited review articles covering major topics in cardiovascular basic science. Typically commissioned from recognized experts but proposals are considered. These receive high citations and define field perspectives.

Research Commentary

1,500 words

Invited perspectives on recently published research articles, either in Circ Res or elsewhere. These contextualize findings for broader readership. Authors are typically invited based on expertise.

Letters to the Editor

800 words

Responses to published articles or brief reports of preliminary findings. Rarely used for substantive new data but can address methodological concerns or alternative interpretations of published work.

Landmark Circulation Research Papers

Papers that defined fields and changed science:

  • Hill et al., 2000 - Demonstrated that cardiac hypertrophy involves distinct signaling pathways leading to physiological versus pathological remodeling
  • Bhattacharya et al., 2006 - Identified bone marrow-derived cells contributing to vascular remodeling in atherosclerosis
  • Backs et al., 2006 - Revealed CaM kinase II delta mediates pathological cardiac hypertrophy through HDAC phosphorylation
  • Sayed et al., 2008 - Established microRNA-1 as a key regulator of cardiac conduction and arrhythmia susceptibility
  • Potente et al., 2007 - Demonstrated SIRT1 regulation of endothelial angiogenic functions through FOXO1 deacetylation

Preparing a Circulation Research Submission?

Get pre-submission feedback from reviewers who've published in Circulation Research and know exactly what editors look for.

Run Free Readiness Scan

Need expert depth? Human review from $1,000

NDA-protected
Confidential

Primary Fields

Molecular cardiologyVascular biologyCardiac electrophysiologyHeart failure mechanismsAtherosclerosis and lipid biologyCardiac metabolismHypertension and renal mechanismsCardiac development and regenerationCardiovascular genetics and genomicsInflammation and immunity in CVD